7th International Conference and Expo on Metabolomics
C. Thomas Caskey
Baylor College of Medicine, USA
C.Thomas Caskey, MD, FACP, FACMG, FRSC (Duke Med 62), Board Certified in Internal Medicine, Clinical and Molecular Genetics. Professor, Department of Molecular & Human Genetics-Baylor College of Medicine which he established in 1971. With Dr. Marshall Nirenberg he discovered the “universality“of the Genetic code & elucidated the mechanism of peptide chain termination. Dr. Caskey discovered 34 disease genes including the understanding of triplet repeat disorders (Fragile X & Myotonic Dystrophy). His STR identification system is internationally used by FBI, Interpol, CIA. In 1994 he became Sr. VP of Drug & Vaccine Development at Merck. Member of NAS, NAM, Royal Society of Canada.
Dr. Caskey is currently directing a program of Precision Medicine with Young Presidents Organization (YPO),Consultant to Human Longevity, and member of the Board of Metabolon. His current research focuses on the application of whole genome sequence and metabolomics of individuals for disease risk and its prevention